ArticleResearch square2025
Sequential Patterns and Transition Timelines of Chronic Disease Comorbidities in Obesity: Evidence from the ELSA database.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Objective: To characterize the sequential patterns and transition timelines of chronic disease comorbidities in population with obesity. Methods: We analyzed population with obese from the English Longitudinal Study of Ageing, including 22,355 independent participants for using association rule mining (ARM) to identify comorbidity patterns and 92,092 person-observations to analyze disease progression pathways and transition probability by multi-stage Markov chain (MMC). Health burden was compared between different onset disease. Results: ARM identified cardiovascular (CVD), metabolic (MTD), and skeletal-muscular disease (SMD) as the most prevalent disease trio. MMC revealed 40% of obese individual will develop a chronic disease within 5 years, and nearly 30% with MTD or CVD will develop to the trio within 10 years. Progression times to the trio differed significantly based on initial disease type ( Conclusions: These findings establish quantifiable transition probabilities and timelines for chronic disease progression, emphasizing the important role of onset disease and contributing empirical evidence for the sequential nature of multimorbidity development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.